相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives
Chiara Sassoli et al.
CURRENT MOLECULAR MEDICINE (2022)
Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions
Chrishan S. Samuel et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2
Ashish Sethi et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases
Sergio Mallart et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target
Daniele Bani
DRUG DISCOVERY TODAY (2020)
On-resin microwave-assisted copper-catalyzed azide-alkyne cycloaddition of H1-relaxin B single chain 'stapled' analogues
Annunziata D'Ercole et al.
PEPTIDE SCIENCE (2020)
Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs
Avinash Muppidi et al.
BIOCONJUGATE CHEMISTRY (2019)
Single chain peptide agonists of relaxin receptors
Praveen Praveen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Copper-catalyzed Azide-alkyne Cycloaddition (CuAAC)-mediated Macrocyclization of Peptides: Impact on Conformation and Biological Activity
Chiara Testa et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1
Alexander I. Agoulnik et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)
Sarah A. Marshall et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Models to Predict Intestinal Absorption of Therapeutic Peptides and Proteins
Filipa Antunes et al.
CURRENT DRUG METABOLISM (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS
R. A. D. Bathgate et al.
PHYSIOLOGICAL REVIEWS (2013)
Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
Chiara Sassoli et al.
PLOS ONE (2013)
Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1
Jingbo Xiao et al.
NATURE COMMUNICATIONS (2013)
Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone
Fazel Shabanpoor et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The Minimal Active Structure of Human Relaxin-2
Mohammed Akhter Hossain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Conventional and microwave-assisted SPPS approach: a comparative synthesis of PTHrP(1-34)NH2
Fabio Rizzolo et al.
JOURNAL OF PEPTIDE SCIENCE (2011)
Posttranslationally Modified Peptides Efficiently Mimicking Neoantigen: A Challenge for Theragnostics of Autoimmune Diseases
Francesca Nuti et al.
BIOPOLYMERS (2010)
Activation of Relaxin-Related Receptors by Short, Linear Peptides Derived from a Collagen-Containing Precursor
Ronen Shemesh et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Relaxin and Nitric Oxide Signalling
M. C. Baccari et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
Regulation of Receptor Signaling by Relaxin A Chain Motifs DERIVATION OF PAN-SPECIFIC AND LGR7-SPECIFIC HUMAN RELAXIN ANALOGS
Jae-Il Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A novel, simple bioactivity assay for relaxin based on inhibition of platelet aggregation
Daniele Bani et al.
REGULATORY PEPTIDES (2007)
Relaxin Family Peptide Receptors - former orphans reunite with their parent ligands to activate multiple signalling pathways
M. L. Halls et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
International union of pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptides
RA Bathgate et al.
PHARMACOLOGICAL REVIEWS (2006)
Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8)
ML Halls et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3′,5′-monophosphate by relaxin
BT Nguyen et al.
MOLECULAR ENDOCRINOLOGY (2003)
分享论文
